186
Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP et al (1991) Oxygen radicals
generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest
87:2056–2066
Ambrosio G, Zweierj JL, Duilio C, Kuppusamyj P, Santoro G, Elia PP et al (1993) Evidence that
mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit
hearts subjected to ischemia and reflow. J Biol Chem 268:18532–18541
Angeletti RH, Aardal S, Serck-Hanssen G, Gee P, Helle KB (1994) Vasoinhibitory activity of
synthetic peptides from the amino terminus of chromogranin A. Acta Physiol Scand 152:11–19
Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK et al (2008) The anti-
hypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator
of cardiac inotropism and lusitropism. Endocrinology 149:4780–4793
Angelone T, Quintieri AM, Pasqua T, Gentile S, Tota B, Mahata SK et al (2012) Phosphodiesterase
type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive
catestatin. Am J Physiol Heart Circ Physiol 302:H431–H442
Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F et al (2015) The NO stimu-
lator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat
hearts. Nitric Oxide 50:10–19
Baldwin AL, Thurston G (2001) Mechanics of endothelial cell architecture and vascular perme-
ability. Crit Rev Biomed Eng 29:247–278
Bassino E, Fornero S, Gallo MP, Gallina C, Femminò S, Levi R et al (2015) Catestatin exerts
direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulat-
ing PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential. PLoS One
10:e0119790
Beauchamp P, Richard V, Tamion F, Lallemand F, Lebreton JP, Vaudry H et al (1999) Protective
effects of preconditioning in cultured rat endothelial cells : effects on neutrophil adhesion and
expression of ICAM-1 after anoxia and reoxygenation. Circulation 100:541–546
Bell RM, Mocanu MM, Yellon DM (2011) Retrograde heart perfusion: the Langendorff technique
of isolated heart perfusion. J Mol Cell Cardiol 50:940–950
Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008a)
Cardioprotection by ischemic postconditioning is lost in aged and STAT3- deficient mice. Circ
Res 102:131–135
Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R (2008b) The myocardial JAK/
STAT pathway: from protection to failure. Pharmacol Therap 120:172–185
Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition
pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic
Res Cardiol 105:771–785
Boengler K, Heusch G, Schulz R (2011) Mitochondria in postconditioning. Antioxid Redox Signal
14:863–880
Bolli R (2001) Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide
in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell
Cardiol 33:1897–1918
Brar BK, Helgeland E, Mahata SK, Zhang K, O’Connor DT, Helle KB et al (2010) Human cates-
tatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart. Regul
Pept 165:63–70
Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo R et al (2007) Human recombinant
chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide
signaling mechanism. Am J Physiol Heart Circ Physiol 293:H719–H727
Carroll R, Gant VA, Yellon DM (2001) Mitochondrial KAT P channels protects a human atrial-
derived cell line by a mechanism involving free radical generation. Cardiovasc Res 51:691–700
Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B et al (2002) Chromogranin
A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart
J 23:967–974
C. Penna and P. Pagliaro